Xiaolong Fu

4.4k total citations · 2 hit papers
193 papers, 3.1k citations indexed

About

Xiaolong Fu is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Xiaolong Fu has authored 193 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pulmonary and Respiratory Medicine, 54 papers in Radiology, Nuclear Medicine and Imaging and 41 papers in Oncology. Recurrent topics in Xiaolong Fu's work include Lung Cancer Diagnosis and Treatment (66 papers), Lung Cancer Treatments and Mutations (39 papers) and Radiomics and Machine Learning in Medical Imaging (32 papers). Xiaolong Fu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (66 papers), Lung Cancer Treatments and Mutations (39 papers) and Radiomics and Machine Learning in Medical Imaging (32 papers). Xiaolong Fu collaborates with scholars based in China, United States and Germany. Xiaolong Fu's co-authors include Deyou Li, Hongjie Wang, Xianzhu Wei, Guoliang Jiang, Wen Yu, Zhenggui Li, Xu‐Wei Cai, Wang An-yu, Long Chen and Shi‐Xiong Liang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Renewable and Sustainable Energy Reviews.

In The Last Decade

Xiaolong Fu

167 papers receiving 3.0k citations

Hit Papers

Multicenter, single-arm, phase II trial of camrelizumab a... 2022 2026 2023 2024 2022 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    2022 161 citations Jun Liu, Yang Yang et al. Journal for ImmunoTherapy of Cancer profile →
  2. Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth
    2023 107 citations Xiaolong Fu, Renjie Chai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Fu China 31 1.4k 748 740 637 519 193 3.1k
Richard Greiner Switzerland 31 1.2k 0.9× 337 0.5× 1.6k 2.2× 2.2k 3.5× 236 0.5× 152 5.9k
Toshiyuki Sawa Japan 31 1.7k 1.2× 112 0.1× 1.9k 2.5× 193 0.3× 1.5k 2.9× 383 4.8k
Toshikazu Takeda Japan 23 363 0.3× 84 0.1× 160 0.2× 393 0.6× 59 0.1× 283 3.1k
Prateek Prasanna United States 25 1.0k 0.7× 2.8k 3.7× 533 0.7× 199 0.3× 25 0.0× 111 3.8k
Jong Min Park South Korea 24 781 0.6× 948 1.3× 130 0.2× 199 0.3× 105 0.2× 190 2.1k
F. Edward Boas United States 19 375 0.3× 973 1.3× 200 0.3× 249 0.4× 27 0.1× 60 2.2k
Pengfei Song United States 39 437 0.3× 3.1k 4.1× 657 0.9× 419 0.7× 815 1.6× 174 5.3k
Jin Hee Ahn South Korea 29 403 0.3× 150 0.2× 550 0.7× 317 0.5× 172 0.3× 157 2.5k
Wenjun Liao China 26 317 0.2× 306 0.4× 478 0.6× 239 0.4× 84 0.2× 156 2.3k
Wei Xia China 27 481 0.3× 1.0k 1.4× 256 0.3× 134 0.2× 65 0.1× 114 2.1k

Countries citing papers authored by Xiaolong Fu

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Fu more than expected).

Fields of papers citing papers by Xiaolong Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Fu. The network helps show where Xiaolong Fu may publish in the future.

Co-authorship network of co-authors of Xiaolong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Fu. A scholar is included among the top collaborators of Xiaolong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Fu. Xiaolong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Chengjian, Mao Yang, Hongbing Chen, et al.. (2025). Structure-Activity relationship of proton exchange membrane for nuclear wastewater under gamma radiation. Separation and Purification Technology. 363. 132340–132340. 1 indexed citations
2.
3.
Fu, Xiaolong, et al.. (2024). Instability flow mechanism of ultra-high head pumped-storage units during turbine runaway process. Sustainable Energy Technologies and Assessments. 71. 104028–104028. 7 indexed citations
4.
Qian, Liqiang, Hao Wang, K. Wang, et al.. (2024). Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells. Translational Oncology. 48. 102074–102074. 2 indexed citations
5.
Zeng, Ya, Xi Su, Jingyi Jia, et al.. (2024). Propensity-matched study on locally advanced esophageal cancer: surgery versus post-operative radiotherapy. Radiation Oncology. 19(1). 130–130. 1 indexed citations
6.
Liu, Ziyi, Hanbing Zhang, Guodong Hong, et al.. (2024). Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice. Molecular Therapy. 32(5). 1387–1406. 39 indexed citations
7.
Fu, Xiaolong, Deyou Li, Hongjie Wang, Daqing Qin, & Xianzhu Wei. (2023). Cavitation mechanism and effect on pump power-trip transient process of a pumped-storage unit. Journal of Energy Storage. 66. 107405–107405. 11 indexed citations
8.
Li, Deyou, et al.. (2023). Synergistic effects of vapor and gaseous cavitation and mass-transfer mechanism in a mechanical pump. Physics of Fluids. 35(5). 13 indexed citations
9.
Guo, Hongwei, et al.. (2023). Physics-informed deep learning for three-dimensional transient heat transfer analysis of functionally graded materials. Computational Mechanics. 72(3). 513–524. 51 indexed citations
10.
Shao, Yan, Wen Feng, Qin Zhang, et al.. (2023). Dosiomics and radiomics improve the prediction of post‐radiotherapy neutrophil‐lymphocyte ratio in locally advanced non‐small cell lung cancer. Medical Physics. 51(1). 650–661. 7 indexed citations
11.
Liu, Jun, Yang Yang, Zhichao Liu, et al.. (2022). Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(3). e004291–e004291. 161 indexed citations breakdown →
12.
Fu, Xiaolong, et al.. (2022). Mobile Robot Combination Autonomous Behavior Strategy to Inspect Hazardous Gases in Relatively Narrow Man–Machine Environment. Chinese Journal of Mechanical Engineering. 35(1). 2 indexed citations
13.
14.
15.
Xia, Bing, Lingzhi Hong, Xu‐Wei Cai, et al.. (2014). Phase 2 Study of Accelerated Hypofractionated Thoracic Radiation Therapy and Concurrent Chemotherapy in Patients With Limited-Stage Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 91(3). 517–523. 30 indexed citations
16.
Fu, Xiaolong, et al.. (2014). Safety of Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 90(1). S11–S12. 1 indexed citations
17.
Wu, Bin, et al.. (2013). Characteristics of Lymph Node Recurrence After Radical Surgery and Their Value in Target Volume Delineation in Postoperative Radiation Therapy for Thoracic Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 87(2). S298–S298. 1 indexed citations
18.
Xu, Zhiyong, et al.. (2011). Application of dose heterogeneity in the target volume in intensity-modulated radiation therapy of esophageal cancer. Zhonghua fangshe yixue yu fanghu zazhi. 31(4). 453–455.
19.
Zhu, Zhengfei, Zhiyong Xu, Weigang Hu, et al.. (2010). Impact of different beam set-up methods on quality of intensity modulated radiation therapy in nonsmall cell lung cancer. Zhonghua fangshe yixue yu fanghu zazhi. 30(5). 576–579. 1 indexed citations
20.
Fu, Xiaolong, et al.. (2010). Research and implementation of scientific research supporting system in digital campus. 176–180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Greiner Breakdown of academic impact, for papers by Toshiyuki Sawa Breakdown of academic impact, for papers by Toshikazu Takeda Breakdown of academic impact, for papers by Prateek Prasanna Breakdown of academic impact, for papers by Jong Min Park Breakdown of academic impact, for papers by F. Edward Boas Breakdown of academic impact, for papers by Pengfei Song Breakdown of academic impact, for papers by Jin Hee Ahn Breakdown of academic impact, for papers by Wenjun Liao Breakdown of academic impact, for papers by Wei Xia
Rankless by CCL
2026